GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen


GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Sanofi strengthens its presence in Algeria with €70 million investment

Sanofi strengthens its presence in Algeria with €70 million investment


French drug major Sanofi revealed today that construction has begun on its new Sidi Abdellah industrial…

Cardio-vascularDiabetesFinancialPharmaceuticalProductionRest of the WorldSanofi

Cardiome in deal for commercialization of Brinavess in Israel


Canada-based Cardiome Pharma (TSX: COM) has entered into an agreement with Tzamal Medical to sell and…

BrinavessCardio-vascularCardiome PharmaLicensingPharmaceuticalRest of the WorldTzamal Medical

Hikma adds to stake in Promopharm; gets US appro for argatroban


Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

Karo Bio and Alkem Labs collaborate to develop eprotirome


Sweden’s Karo Bio AB (STO KARO) and Indian drugmaker Alkem Laboratories have entered into a collaboration…

Alkem LaboratoriesAsia-PacificCardio-vasculareprotiromeKaro BioLicensingPharmaceuticalResearchRest of the World

South Africa provinces face drug “stock-outs” due to overspending


As a result of enormous provincial overspends, provinces of South Africa have seen health facilities…

Anti-viralsCardio-vascularFinancialHealthcareMarkets & MarketingPharmaceuticalRest of the WorldVaccines

Ranbaxy to launch Daiichi Sankyo’s olmesartan in six African markets


Indian drug major Ranbaxy Laboratories, which is majority owned by Japan’s Daiichi Sankyo, is to…

Amlodipine BesylateBenicarCardio-vascularDaiichi SankyoNorvascolmesartanPharmaceuticalRanbaxy LaboratoriesRest of the WorldSankyo

Back to top